A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies

MLA

Li, Ew, et al. “A Single-Day Polychemotherapy Regimen with Proteasome Inhibitor Combinations for Relapsed/Refractory Myeloma in the Era of Novel Therapies.” Urn:ISSN:0902-4441, 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1458866717&authtype=sso&custid=ns315887.

APA

Li, E., Jones, E., Bryant, C., King, T., Talaulikar, D., Ng, J., Bryant, A. ; https://orcid. org/000.-0000-1621-4327, Ridha, Z., Doo, N., Menzies, A., Ling, S. ; https://orcid. org/000.-0001-9739-7101, Ho, S., Abadir, E., Vanguru, V., Joshua, D., & Ho, P. (2024). A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. Urn:ISSN:0902-4441.

Chicago

Li, Ew, E Jones, C Bryant, T King, D Talaulikar, Jy Ng, A ; https://orcid.org/0009-0000-1621-4327 Bryant, et al. 2024. “A Single-Day Polychemotherapy Regimen with Proteasome Inhibitor Combinations for Relapsed/Refractory Myeloma in the Era of Novel Therapies.” Urn:ISSN:0902-4441. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1458866717&authtype=sso&custid=ns315887.